{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:16:28Z","timestamp":1788336988447,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.endinu.2017.05.009","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T14:00:54Z","timestamp":1499176854000},"page":"384-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects"],"prefix":"10.1016","volume":"64","author":[{"given":"Moises","family":"Mercado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Melgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latife","family":"Salame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.endinu.2017.05.009_bib0585","first-page":"1","article-title":"CBTRUS Statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neurol Oncol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0590","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.endinu.2017.05.009_bib0595","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.beem.2009.05.001","article-title":"Pituitary tumours: pituitary incidentalomas","volume":"23","author":"Molitch","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0600","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas, a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.endinu.2017.05.009_bib0605","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.beem.2011.07.003","article-title":"Pituitary incidentaloma","volume":"26","author":"Orija","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0610","first-page":"2172","article-title":"Epidemiology of pituitary adenoma: results of the first Swiss study","volume":"5","author":"Fontana","year":"2009","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.endinu.2017.05.009_bib0615","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0620","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992\u20132007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0625","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0144","article-title":"The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011","volume":"171","author":"Tj\u00f6rnstrand","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0630","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0635","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1590\/2359-3997000000195","article-title":"Incidence and prevalence of clinically-relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina","volume":"60","author":"Fainstein Day","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0640","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11102-006-0412-9","article-title":"Clinically non-functioning pituitary adenoma","volume":"9","author":"Jaffe","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.endinu.2017.05.009_bib0645","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ecl.2007.10.011","article-title":"Nonfunctioning pituitary tumors and pituitary incidentalomas","volume":"37","author":"Molitch","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endinu.2017.05.009_bib0650","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1677\/erc.0.0070029","article-title":"The epidemiology of endocrine tumours","volume":"7","author":"Monson","year":"2000","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.endinu.2017.05.009_bib0655","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11102-008-0158-7","article-title":"The molecular biology of pituitary tumors: a personal perspective","volume":"12","author":"Grossman","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.endinu.2017.05.009_bib0660","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0665","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Afflorei","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0670","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0675","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.beem.2010.03.003","article-title":"Clinical and molecular genetics of Carney complex","volume":"24","author":"Rothenbuhler","year":"2010","journal-title":"Best Pract Res Cli Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0680","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers","volume":"100","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2015","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0685","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-16-0452","article-title":"Novel genetic causes of pituitary adenomas","volume":"22","author":"Caimari","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.endinu.2017.05.009_bib0690","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0695","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(03)00452-6","article-title":"Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!","volume":"546","author":"Stergiopolus","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.endinu.2017.05.009_bib0700","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endinu.2017.05.009_bib0705","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1158\/1078-0432.CCR-1127-3","article-title":"Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease","volume":"10","author":"Simpson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.endinu.2017.05.009_bib0710","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/er.2006-0042","article-title":"Pituitary tumor-transforming gene: physiology and implications for tumorigenesis","volume":"28","author":"Vlotides","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endinu.2017.05.009_bib0715","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2265.2003.01598.x","article-title":"Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour","volume":"58","author":"McCabe","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0720","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2265.2006.02630.x","article-title":"Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study","volume":"65","author":"Filippella","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0725","doi-asserted-by":"crossref","first-page":"E796","DOI":"10.1210\/jc.2012-4028","article-title":"Whole-exome sequencing studies of nonfunctioning pituitary adenomas","volume":"98","author":"Newey","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0730","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO;2-3","article-title":"Pituitary carcinoma: a clinicopathologic study of 15 cases","volume":"79","author":"Pernicone","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.endinu.2017.05.009_bib0735","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/foc.2004.16.4.8","article-title":"Pituitary carcinoma: a review of the literature","volume":"16","author":"Ragel","year":"2004","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.endinu.2017.05.009_bib0740","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000318499","article-title":"Pituitary carcinomas","volume":"38","author":"Colao","year":"2010","journal-title":"Front Horm Res"},{"key":"10.1016\/j.endinu.2017.05.009_bib0745","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1210\/jc.2011-2031","article-title":"Clinical review: pituitary carcinoma: difficult diagnosis and treatment","volume":"96","author":"Heaney","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0750","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature05268","article-title":"Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints","volume":"444","author":"Bartkova","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.endinu.2017.05.009_bib0755","doi-asserted-by":"crossref","first-page":"10564","DOI":"10.1158\/0008-5472.CAN-07-0974","article-title":"Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth","volume":"67","author":"Chesnokova","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.endinu.2017.05.009_bib0760","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.0804810105","article-title":"p21(Cip1) restrains pituitary tumor growth","volume":"105","author":"Chesnokova","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.endinu.2017.05.009_bib0765","first-page":"241","article-title":"Aneuploidy, centrosome alteration and securin overexpression as features of pituitary somatotroph and lactotroph adenomas","volume":"27","author":"Uccella","year":"2005","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0770","doi-asserted-by":"crossref","first-page":"e5268","DOI":"10.1097\/MD.0000000000005268","article-title":"Genetic aspects of pituitary carcinoma: a systematic review","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.endinu.2017.05.009_bib0775","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12020-016-0940-7","article-title":"Non-functioning pituitary adenomas: growth and aggressiveness","volume":"53","author":"\u00d8ystese","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.endinu.2017.05.009_bib0780","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2008-0643","article-title":"Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0785","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bjo.75.4.219","article-title":"Pituitary adenomas: automatic static perimetry and Goldmann perimetry. A comparative study of 345 visual field charts","volume":"75","author":"Grochowicki","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0790","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.eye.6700165","article-title":"Criteria for early detection of temporal hemianopia in asymptomatic pituitary tumor","volume":"16","author":"Fujimoto","year":"2002","journal-title":"Eye"},{"key":"10.1016\/j.endinu.2017.05.009_bib0795","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1600-0420.2004.00348.x","article-title":"Neuro-ophthalmic findings in sarcoidosis","volume":"82","author":"Heuser","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.endinu.2017.05.009_bib0800","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/01658107.2014.928826","article-title":"Isolated pupil-involving third nerve palsy as the first presentation of sarcoidosis","volume":"38","author":"Bansal","year":"2014","journal-title":"Neuroophthalmol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0805","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pediatrneurol.2013.10.014","article-title":"Central nervous system involvement in hemophagocytic lymphohistiocytosis: a single-center experience","volume":"50","author":"Jovanovic","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0810","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3171\/2014.12.JNS14870","article-title":"Pituitary metastasis: current practice in Japan","volume":"123","author":"Habu","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.endinu.2017.05.009_bib0815","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.pjnns.2016.08.007","article-title":"Hypophyseal metastatsis: a report of three cases and literature review","volume":"50","author":"Ravnik","year":"2016","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0820","doi-asserted-by":"crossref","first-page":"756069","DOI":"10.1155\/2015\/756069","article-title":"Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas","volume":"2015","author":"Vargas","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0825","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/EJE-10-0651","article-title":"Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on out-come","volume":"164","author":"M\u00f6ller-Goede","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0830","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4158\/EP14120.OR","article-title":"Pituitary apoplexy in nonfunctioning pituitary macroadenomas: a case\u2013control study","volume":"20","author":"Vargas","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.endinu.2017.05.009_bib0835","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ecl.2014.10.016","article-title":"Pituitary apoplexy","volume":"44","author":"Briet","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endinu.2017.05.009_bib0840","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1530\/EJE-14-0794","article-title":"Pituitary tumor apoplexy","volume":"172","author":"Capatina","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0845","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1227\/01.neu.0000303191.57178.2a","article-title":"Clinical relevance of precipitating factors in pituitary apoplexy","volume":"61","author":"Semple","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.endinu.2017.05.009_bib0850","first-page":"623","article-title":"Pathology of human and experimental pituitary tumors","volume":"54","author":"Treip","year":"1961","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.endinu.2017.05.009_bib0855","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00418-008-0472-1","article-title":"Pathology of the human pituitary adenomas","volume":"130","author":"Osamura","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0860","first-page":"152","article-title":"Novel aspects in histopathology of the pituitary gland","volume":"64","author":"Tortosa","year":"2017","journal-title":"Endocrinol Diab Nutr"},{"key":"10.1016\/j.endinu.2017.05.009_bib0865","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.5858\/2008-132-1231-PPPWDT","article-title":"Practical pituitary pathology: what does the pathologist need to know","volume":"132","author":"Asa","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.endinu.2017.05.009_bib0870","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5858\/arpa.2016-0082-OA","article-title":"A rational starting place for the immunohistochemical characterization of pituitary adenomas","volume":"141","author":"McDonald","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.endinu.2017.05.009_bib0875","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","article-title":"Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics","volume":"26","author":"Balogun","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0880","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","article-title":"Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes","volume":"1","author":"Cooper","year":"2010","journal-title":"Horm Cancer"},{"key":"10.1016\/j.endinu.2017.05.009_bib0885","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12022-009-9094-y","article-title":"Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas","volume":"4","author":"Wang","year":"2009","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0890","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ecl.2014.11.001","article-title":"Silent pituitary adenomas","volume":"44","author":"Mayson","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endinu.2017.05.009_bib0895","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-16-0738","article-title":"Silent somatotroph tumor revisited from a study of 80 patients with and without acromegaly and review of the literature","volume":"176","author":"Chinezu","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2016.00001","article-title":"Multiple pituitary adenomas: a systematic review","volume":"7","author":"Budan","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0905","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/jc.2011-3163","article-title":"Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study","volume":"97","author":"Ram\u00edrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0910","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jc.2003-030859","article-title":"Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/eje.1.02313","article-title":"Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas","volume":"156","author":"Taboada","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0920","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00000478-198609000-00003","article-title":"The use of the monoclonal antigen Ki-67 in the identification of proliferating cells: application to surgical neuropathology","volume":"10","author":"Burger","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0925","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11102-010-0242-7","article-title":"The clinical significance of MiB-1 labeling index in pituitary adenomas","volume":"13","author":"Chacko","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.endinu.2017.05.009_bib0930","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ando.2015.04.002","article-title":"Management of clinically non-functioning pituitary adenoma","volume":"76","author":"Chanson","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.endinu.2017.05.009_bib0935","series-title":"World Health Organization classification of tumours: tumours of the endocrine organs","author":"DeLellis","year":"2004"},{"key":"10.1016\/j.endinu.2017.05.009_bib0940","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00401-005-1099-0","article-title":"The WHO classification of human pituitary tumors: comments","volume":"111","author":"Figarella-Bronger","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0945","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3171\/2010.8.JNS10290","article-title":"Atypical pituitary adenomas: incidence, clinical characteristics and implications","volume":"114","author":"Zada","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.endinu.2017.05.009_bib0950","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00701-003-0174-3","article-title":"Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas \u2013 a study on 721 patients","volume":"146","author":"Nomikos","year":"2004","journal-title":"Acta Neurochirug"},{"key":"10.1016\/j.endinu.2017.05.009_bib0955","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2004-820914","article-title":"Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery","volume":"112","author":"Wichers-Rother","year":"2004","journal-title":"Exp Clin Endocrinol Diab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0960","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2005-2552","article-title":"Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma","volume":"91","author":"Dekkers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0965","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2265.2003.01784.x","article-title":"Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth","volume":"58","author":"Greenman","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0970","first-page":"3507","article-title":"Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas","volume":"80","author":"Arafah","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib0975","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0980","first-page":"111","article-title":"Current diagnosis and treatment of hyperprolactinemia","volume":"54","author":"Melgar","year":"2016","journal-title":"Rev Med IMSS"},{"key":"10.1016\/j.endinu.2017.05.009_bib0985","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","article-title":"Pathophysiological classification of pituitary tumors: 10 years experience with the German Pituitary Tumor Registry","volume":"156","author":"Saeger","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib0990","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/edrv-6-4-552","article-title":"Gonadotroph cell adenomas of the pituitary","volume":"6","author":"Snyder","year":"1985","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endinu.2017.05.009_bib0995","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0046-8177(97)90005-8","article-title":"The clinicopathological characteristics of gonadotroph cell adenoma: a study of 118 cases","volume":"2","author":"Ho","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1000","first-page":"1255","article-title":"Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone","volume":"77","author":"Daneshdoost","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib1005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM199102283240904","article-title":"Recognition of gonadotroph adenomas in women","volume":"324","author":"Daneshdoost","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endinu.2017.05.009_bib1010","first-page":"591","article-title":"Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation","volume":"80","author":"Djerassi","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib1015","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","article-title":"Hypopituitarism","volume":"388","author":"Higham","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.endinu.2017.05.009_bib1020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","article-title":"Which patients do not require a GH stimulation test for the diagnosis of GH deficiency","volume":"87","author":"Hartman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib1025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clineuro.2006.11.001","article-title":"Imaging of sellar and parasellar lesions","volume":"109","author":"Rennert","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.endinu.2017.05.009_bib1030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000442327","article-title":"Magnetic resonance imaging of pituitary tumors","volume":"45","author":"Bonneville","year":"2016","journal-title":"Front Horm Res"},{"key":"10.1016\/j.endinu.2017.05.009_bib1035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12022-012-9208-9","article-title":"Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas","volume":"23","author":"Nishioka","year":"2012","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.1995.00430020067008","article-title":"The natural history of the pituitary inicidentaloma","volume":"155","author":"Donovan","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.endinu.2017.05.009_bib1045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/eje.0.1490123","article-title":"A survey of pituitary incidentaloma in Japan","volume":"149","author":"Sano","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11102-005-1757-1","article-title":"Retrospective multicentric study of pituitary incidentalomas","volume":"7","author":"Fainstein Day","year":"2004","journal-title":"Pituitary"},{"key":"10.1016\/j.endinu.2017.05.009_bib1055","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/jns.2006.104.6.884","article-title":"Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow up examination","volume":"104","author":"Arita","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.endinu.2017.05.009_bib1060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.1.02334","article-title":"The natural course of non-functioning pituitary macroadenomas","volume":"156","author":"Dekkers","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1065","first-page":"938","article-title":"What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol","volume":"67","author":"Karavitaki","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib1070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-16-0041","article-title":"Analysis and natural history of pituitary incidentalomas","volume":"175","author":"Imran","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1075","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2010-1054","article-title":"Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis","volume":"96","author":"Fern\u00e1ndez-Balsells","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib1080","first-page":"350","article-title":"Hypophyseal macroadenomas. A neurosurgical challenge","volume":"71","author":"Guinto","year":"2003","journal-title":"Cir Cir"},{"key":"10.1016\/j.endinu.2017.05.009_bib1085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ando.2015.04.007","article-title":"Non-functioning pituitary adenoma: when and how to operate? What pathologic criteria for typing","volume":"76","author":"Castinetti","year":"2015","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ecl.2014.10.010","article-title":"Outcomes of endoscopic transsphenoidal surgery","volume":"44","author":"Dallapiazza","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endinu.2017.05.009_bib1095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-11-0566","article-title":"Can we stop imaging in surgically treated and radiotherapy na\u00efve patients with non-functioning pituitary adenomas","volume":"165","author":"Reddy","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF03347763","article-title":"Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas","volume":"17","author":"Marazuela","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endinu.2017.05.009_bib1105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S1460396913000071","article-title":"Efficacy and safety of external beam radiation therapy in non-functioning pituitary adenomas: a case\u2013control, nested in a cohort study","volume":"13","author":"Vargas","year":"2014","journal-title":"J Radiotherapy Pract"},{"key":"10.1016\/j.endinu.2017.05.009_bib1110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ecl.2014.10.009","article-title":"Efficacy and complications of pituitary irradiation","volume":"44","author":"Ntali","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endinu.2017.05.009_bib1115","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.05.009_bib1120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1530\/eje.0.1500497","article-title":"Doubled mortality rate in irradiated patients reoperated for regrowth of a macroadenoma of the pituitary gland","volume":"150","author":"Erfurth","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP151100.OR","article-title":"Health-related quality of life in patients with nonfunctioning pituitary adenomas undergoing postoperative radiation therapy: a case\u2013control study","volume":"22","author":"Gonz\u00e1lez","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.endinu.2017.05.009_bib1130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11102-007-0018-x","article-title":"Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function","volume":"10","author":"Nielsen","year":"2007","journal-title":"Pituitary"},{"key":"10.1016\/j.endinu.2017.05.009_bib1135","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cen.12967","article-title":"Health-related quality of life in patients treated for nonfunctioning pituitary adenomas during the years 2000\u20132010","volume":"84","author":"Karppinen","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/ERC-07-0271","article-title":"Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study","volume":"15","author":"Florio","year":"2008","journal-title":"Endocr-Rel Cancer"},{"key":"10.1016\/j.endinu.2017.05.009_bib1145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1385\/ENDO:20:3:279","article-title":"Somatostatin analogs in the treatment of non-GH secreting pituitary adenomas","volume":"20","author":"Colao","year":"2003","journal-title":"Endocrine"},{"key":"10.1016\/j.endinu.2017.05.009_bib1150","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/ERC-08-0181","article-title":"Medical therapy for nonfunctioning pituitary adenomas","volume":"15","author":"Colao","year":"2008","journal-title":"Endocr-Rel Cancer"},{"key":"10.1016\/j.endinu.2017.05.009_bib1155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-16-0206","article-title":"Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists","volume":"175","author":"Greenman","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.05.009_bib1160","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/jc.2015-3653","article-title":"Pituitary medicine from discovery to patient-focused outcomes","volume":"101","author":"Melmed","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417301635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417301635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T22:54:05Z","timestamp":1636239245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016417301635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":116,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2530016417301635"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2017.05.009","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2017.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SEEN. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}